1. Home
  2. SLNO vs ENPH Comparison

SLNO vs ENPH Comparison

Compare SLNO & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • ENPH
  • Stock Information
  • Founded
  • SLNO 1999
  • ENPH 2006
  • Country
  • SLNO United States
  • ENPH United States
  • Employees
  • SLNO N/A
  • ENPH N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ENPH Semiconductors
  • Sector
  • SLNO Health Care
  • ENPH Technology
  • Exchange
  • SLNO Nasdaq
  • ENPH Nasdaq
  • Market Cap
  • SLNO 3.8B
  • ENPH 4.2B
  • IPO Year
  • SLNO 2014
  • ENPH 2012
  • Fundamental
  • Price
  • SLNO $57.52
  • ENPH $38.15
  • Analyst Decision
  • SLNO Strong Buy
  • ENPH Hold
  • Analyst Count
  • SLNO 10
  • ENPH 30
  • Target Price
  • SLNO $112.50
  • ENPH $59.13
  • AVG Volume (30 Days)
  • SLNO 2.2M
  • ENPH 8.4M
  • Earning Date
  • SLNO 11-05-2025
  • ENPH 10-21-2025
  • Dividend Yield
  • SLNO N/A
  • ENPH N/A
  • EPS Growth
  • SLNO N/A
  • ENPH 37.10
  • EPS
  • SLNO N/A
  • ENPH 1.28
  • Revenue
  • SLNO $32,656,999.00
  • ENPH $1,482,823,000.00
  • Revenue This Year
  • SLNO N/A
  • ENPH $12.97
  • Revenue Next Year
  • SLNO $181.85
  • ENPH N/A
  • P/E Ratio
  • SLNO N/A
  • ENPH $31.73
  • Revenue Growth
  • SLNO N/A
  • ENPH 4.39
  • 52 Week Low
  • SLNO $41.50
  • ENPH $29.89
  • 52 Week High
  • SLNO $90.32
  • ENPH $118.13
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 39.31
  • ENPH 51.93
  • Support Level
  • SLNO $53.88
  • ENPH $37.45
  • Resistance Level
  • SLNO $72.99
  • ENPH $40.86
  • Average True Range (ATR)
  • SLNO 4.75
  • ENPH 2.08
  • MACD
  • SLNO 0.04
  • ENPH 0.07
  • Stochastic Oscillator
  • SLNO 33.61
  • ENPH 46.32

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About ENPH Enphase Energy Inc.

Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.

Share on Social Networks: